» Articles » PMID: 15225113

Platelet Activation in Myocardial Ischemic Syndromes

Overview
Date 2004 Jul 1
PMID 15225113
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Platelets play a central role in the pathogenesis of atherosclerosis and thrombosis. Platelet adhesion and aggregate formation are critical events that occur in unstable coronary syndromes. Platelet activation precedes the formation of homotypic and heterotypic aggregates. In the last 10 years, researchers have described the presence of activated platelets in the systemic circulation in various cardiovascular disease states, particularly acute coronary syndromes. This review describes the evidence for platelet activation in acute myocardial ischemic syndromes, describes the pathophysiology responsible for its occurrence, and discusses how platelet activation and reactivity may affect the use of concomitant drug therapies and patient prognosis.

Citing Articles

Absence of platelet overactivation and thrombosis formation among patients with coronary atherosclerosis disease after vaccination against SARS-CoV-2.

Xu H, Zhao X, Zhang P, Zhang Y, Zhou Q, Wu H Heliyon. 2024; 10(20):e38336.

PMID: 39640769 PMC: 11619953. DOI: 10.1016/j.heliyon.2024.e38336.


Early assessment of the pharmacokinetic and pharmacodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response.

Gurbel P, Bliden K, Kundan P, Kraft D, Parekh R, Singh S J Thromb Thrombolysis. 2023; 57(1):21-28.

PMID: 38066385 PMC: 10830588. DOI: 10.1007/s11239-023-02914-7.


A System-Wide Investigation and Stratification of the Hemostatic Proteome in Premature Myocardial Infarction.

Dunster J, Wright J, Samani N, Goodall A Front Cardiovasc Med. 2022; 9:919394.

PMID: 35845083 PMC: 9281867. DOI: 10.3389/fcvm.2022.919394.


International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests.

Gurbel P, Tantry U, Storey R J Thromb Thrombolysis. 2021; 52(4):992-998.

PMID: 34021852 PMC: 8140326. DOI: 10.1007/s11239-021-02465-9.


Net platelet clot strength of thromboelastography platelet mapping assay for the identification of high on-treatment platelet reactivity in post-PCI patients.

Cheng D, Zhao S, Hao Y Biosci Rep. 2020; 40(7).

PMID: 32639536 PMC: 7364512. DOI: 10.1042/BSR20201346.